Osteoclast-derived activity in the coupling of bone formation to resorption

Trends in Molecular Medicine

Volumn 11, Issue 2, 2005, Pages 76-81

  Martin, T John ^a   Sims, Natalie A ^b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN RECEPTOR; CYTOKINE; ESTROGEN; GROWTH FACTOR; MEMBRANE PROTEIN; PARATHYROID HORMONE;

ALBERS SCHOENBERG DISEASE; B LYMPHOCYTE; BIOSYNTHESIS; BONE MATRIX; BONE REMODELING; CELL ACTIVITY; CELL COMMUNICATION; CELL LINEAGE; CELL MATURATION; GENETICS; IMMUNE SYSTEM; INFLAMMATION; MENOPAUSE; MUTATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PERIODONTAL DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 13244267455     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.12.004     Document Type: Article

References (53)

1. H.M. Frost Dynamics of bone remodeling H.M. Frost Bone Biodynamics 1964 Little, Brown & Co 315 333
2. W.H. Harris, and R.P. Heaney Skeletal renewal and metabolic bone disease N. Engl. J. Med. 280 1969 193 202
3. A.M. Parfitt The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis Metab. Bone Dis. Relat. Res. 4 1982 1 6
4. T.J. Martin, and G.A. Rodan Coupling of bone resorption and formation during bone remodeling R. Marcus Osteoporosis 2001 Academic Press 361 372
5. E.F. Eriksen Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease Endocr. Rev. 7 1986 379 408
6. G.A. Rodan, and T.J. Martin Role of osteoblasts in hormonal control of bone resorption - a hypothesis Calcif. Tissue Int. 33 1981 349 351
7. R. Baron Biology of the osteoclast G.R. Mundy T.J. Martin Handbook of Experimental Pharmacology: Physiology and Pharmacology of Bone Vol. 107 1993 Springer-Verlag 111 148
8. N. Udagawa Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function Endocrinology 141 2000 3478 3484
9. T. Suda Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr. Rev. 20 1999 345 357
10. W.J. Boyle Osteoclast differentiation and activation Nature 423 2003 337 342
11. T.J. Martin Interleukins in the control of osteoclast differentiation Crit. Rev. Eukaryot. Gene Expr. 8 1998 107 123
12. G.R. Mundy Hormonal factors which regulate bone resorption G.R. Mundy T.J. Martin Handbook of Experimental Pharmacology: Physiology and Pharmacology of Bone Vol. 107 2003 Springer-Verlag 215 238
13. G.A. Howard Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism Proc. Natl. Acad. Sci. U. S. A. 78 1981 3204 3208
14. S. Mohan, and D.J. Baylink The role of IGF-II in the coupling of bone formation to resorption E.M. Spencer Modern concepts of insulin-like growth factors 1991 Elsevier 19 174
15. M. Centrella Transforming growth factor-β and remodeling of bone J. Bone Joint Surg. Am. 73 1991 1418
16. C. Gray Topographically induced bone formation in vitro: implications for bone implants and bone grafts Bone 18 1996 115 123
17. Sims, N.A. et al. (2004) Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J. Clin. Invest. 113, 379-318
18. M. Nakamura Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption Endocrinology 144 2003 5441 5449
19. A.E. Grigoriadis c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling Science 266 1994 443 448
20. M. Marzia Decreased c-Src expression enhances osteoblast differentiation and bone formation J. Cell Biol. 151 2000 311 320
21. S. Schaller The chloride channel inhibitor n53736 prevents bone resorption in ovariectomized rats without changing bone formation J. Bone Miner. Res. 19 2004 1144 1153
22. Karsdal, M.A. et al. Acidification of the osteoclastic resorption lacunae controls the coupling of bone resorption to bone formation. Am. J. Physiol. (in press)
23. L. Xing Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival Genes Dev. 15 2001 241 253
24. H. Brockstedt Cortical bone remodeling in autosomal dominant osteopetrosis: A study of two different phenotypes Bone 18 1996 67 72
25. R.M. Neer Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N. Engl. J. Med. 344 2001 1434 1441
26. C.A. Frolik Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure Bone 33 2003 372 379
27. H. Dobnig, and R.T. Turner Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells Endocrinology 136 1995 3632 3638
28. R.L. Jilka Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone J. Clin. Invest. 104 1999 439 446
29. D. Stanislaus In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment Bone 27 2000 209 218
30. Y. Jiang Recombinant human parathyroid hormone (1-34) (teriparatide) improves both cortical and cancellous bone structure J. Bone Miner. Res. 18 2003 1932 1941
31. J. Foldes Structural and geometric changes in iliac bone: relationship to normal aging and osteoporosis J. Bone Miner. Res. 6 1991 759 766
32. T.J. Martin, and E. Seeman Reduced bone formation in the pathogenesis of bone fragility T. Bronner C. Farach-Carson Bone Formation: topics in bone biology 2003 Springer 106 119
33. P.D. Delmas The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate - is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16 1995 603 610
34. T.J. Wronski Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats Endocrinology 132 1993 823 831
35. B. Demiralp Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos Endocrinology 143 2002 4038 4047
36. D.M. Black The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis N. Engl. J. Med. 349 2003 1207 1215
37. J.S. Finkelstein The effects of parathyroid hormone, alendronate, or both in men with osteoporosis N. Engl. J. Med. 349 2003 1216 1226
38. S. Khosla Parathyroid hormone plus alendronate - a combination that does not add up N. Engl. J. Med. 349 2003 1277 1279
39. Y.L. Ma Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation Endocrinology 142 2001 4047 4054
40. J.E. Onyia In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats Bone 17 1995 479 484
41. M.E. Holtrop Time-related changes in the ultrastructure of osteoclasts after injection of parathyroid hormone in young rats Calcif. Tissue Int. 27 1979 129 135
42. T.J. Martin Does bone resorption inhibition affect the anabolic response to parathyroid hormone? Trends Endocrinol. Metab. 15 2004 49 50
43. A.O. Hoff Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene J. Clin. Invest. 110 2002 1849 1857
44. R. Dacquin Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo J. Cell Biol. 164 2004 509 514
45. T.J. Martin Calcitonin L.V. Avioli S.M. Krane Metabolic bone disease and related disorders 1998 Academic Press 95 121
46. S.C. Manolagas, and R.L. Jilka Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis N. Engl. J. Med. 332 1995 305 311
47. R.B. Kimble Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period Endocrinology 136 1995 3054 3061
48. M.N. Weitzmann Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency J. Clin. Invest. 110 2002 1643 1650
49. G.A. Rodan, and T.J. Martin Therapeutic approaches to bone diseases Science 289 2000 1508 1514
50. E. Tian The role of the Wnt signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma N. Engl. J. Med. 349 2003 2483 2494
51. G. Rawadi BMP-2 control of alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop J. Bone Min. Res. 18 2003 1841 1853
52. C.J. Day Gene array identification of osteoclast genes: differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor J. Cell. Biochem. 91 2004 303 315
53. M.L. Falany Osteoclasts secrete the chemotacxtic cytokine Mim-1 Biochem. Biophys. Res. Commun. 281 2001 180 185